drugset / Trial / NCT02985697

Safety and Efficacy of Intranasal Dexmedetomidine

NCT02985697

Phase 4 Unknown 100 enrolled Bon Secours Pediatric Dental Associates
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to evaluate the efficacy and safety of intranasal dexmedetomidine when used in combination with oral midazolam and/or nitrous oxide for moderate sedation during pediatric outpatient dental procedures.

Timeline

Start
2017-01
Primary completion
2018-01
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 3 ug/kg Intranasal
Subject Midazolam Small molecule 0.5 mg/kg Oral
Subject Nitrous Oxide Other / unclassified Inhaled

Indications

No indication recorded.